CLINICAL_TRIALS
trial_result
· 2008-04-10
Clinical Trial Update: Amisulpride in Schizophrenic Patients [Phase 4]
Summary
This document reports the completion of a Phase 4 clinical trial of amisulpride for schizophrenia. The sponsor is Sanofi.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED